MFDS — authorised 5 February 2014
- Marketing authorisation holder: SANDOZ
- Status: likely_approved
🇰🇷 Cefpodoxime Proxetil in South Korea
MFDS authorised Cefpodoxime Proxetil on 5 February 2014
Marketing authorisations
MFDS
- Marketing authorisation holder: AUROBINDO PHARMA
- Status: likely_approved
Cefpodoxime Proxetil in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Cefpodoxime Proxetil approved in South Korea?
Yes. MFDS authorised it on 5 February 2014; MFDS has authorised it.
Who is the marketing authorisation holder for Cefpodoxime Proxetil in South Korea?
SANDOZ holds the South Korean marketing authorisation.